申请人:He Kunlun
公开号:US20130158022A1
公开(公告)日:2013-06-20
The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.
本发明涉及化合物I的一种,或其异构体,药学上可接受的盐和溶剂,以及包含化合物I的组合物,或其异构体,药学上可接受的盐和溶剂,以及药学上可接受的载体,赋形剂或稀释剂。本发明还涉及使用化合物I的一种,或其异构体,药学上可接受的盐和溶剂来对抗细胞凋亡,预防或治疗与细胞凋亡相关的疾病或障碍;特别是用于保护心肌细胞,并预防或治疗与心肌细胞凋亡相关的疾病或障碍。